Matti Vanska

Matti Vänskä is Senior Director, Clinical Development at AvenCell Therapeutics, serving as Clinical Lead for hematology programs focused on leukemias and lymphomas. A board-certified hematologist and internist with over 15 years of clinical experience and 5 years in clinical drug development, he provides medical leadership for early-phase clinical programs, overseeing clinical trial conduct, patient safety, protocol development, clinical data interpretation, and program strategy. His work is centered on advancing innovative allogeneic CAR-T therapies for hematologic malignancies, helping translate cutting-edge cellular therapies from early clinical development toward improved patient outcomes.